NEW YORK, Nov 15 (Reuters) - Specialty pharmaceutical company Allergan Inc. (AGN.N: Quote, Profile, Research) has made a $3.2 billion bid for Inamed Corp. (IMDC.O: Quote, Profile, Research) in an attempt to break up Medicis Pharmaceutical Co.'s (MRX.N: Quote, Profile, Research) proposed takeover of Inamed.
